https://infomeddnews.com/nectero-therapeutics-news/
Nectero Therapeutics Reports Two-Year Safety and Efficacy Data from First-in-Human Trial for...
Apr 23, 2026 - The results were presented at Charing Cross 2026 by Dr. Andrew Holden during a session on Abdominal Aortic Aneurysm (AAA) disease management